168 related articles for article (PubMed ID: 6270022)
1. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia.
Mendis LN; Best JM; Banatvala JE
Int J Cancer; 1981 May; 27(5):669-77. PubMed ID: 6270022
[No Abstract] [Full Text] [Related]
2. Herpesvirus antigens as markers for cervical cancer.
Gupta PK; Aurelian L; Frost JK; Carpenter JM; Klacsmann KT; Rosenshein NB; Tyrer HW
Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S232-58. PubMed ID: 6273263
[No Abstract] [Full Text] [Related]
3. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
[TBL] [Abstract][Full Text] [Related]
4. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
[TBL] [Abstract][Full Text] [Related]
5. [Genital herpes and cervical cancer].
Posevaia TA; Barinskiĭ IF
Vopr Virusol; 1983; 28(5):518-30. PubMed ID: 6197814
[No Abstract] [Full Text] [Related]
6. IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix.
El Falaky IH; Vestergaard BF
Eur J Cancer (1965); 1977 Mar; 13(3):247-51. PubMed ID: 193693
[No Abstract] [Full Text] [Related]
7. Specific IgG and IgA antibodies to herpes simplex virus (HSV)-induced surface antigen in patients with HSV infections and in healthy adults.
Hadar T; Sarov I
J Med Virol; 1984; 14(3):201-7. PubMed ID: 6094720
[TBL] [Abstract][Full Text] [Related]
8. Persistence of serum IgA antibodies to herpes simplex, varicella-zoster, cytomegalovirus, and rubella virus detected by enzyme-linked immunosorbent assays.
Morris GE; Coleman RM; Best JM; Benetato BB; Nahmias AJ
J Med Virol; 1985 Aug; 16(4):343-9. PubMed ID: 2993502
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus and human cancer. III. Search for relationship of herpes simplex antibodies and cervical dysplasia and labial neoplasia.
Rotola A; Gerna G; Di Luca D; Virgili AR; Manservigi R; Cassai E
Tumori; 1983 Apr; 69(2):83-7. PubMed ID: 6304957
[TBL] [Abstract][Full Text] [Related]
10. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia.
Kalimo K; Terho P; Honkonen E; Grönroos M; Halonen P
Br J Obstet Gynaecol; 1981 Nov; 88(11):1130-4. PubMed ID: 6271164
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
Chiphangwi JD
IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
[TBL] [Abstract][Full Text] [Related]
13. Uterine cervical dysplasia & herpes simplex virus.
Luthra UK; Kotwani BG; Kochhar M; Khurana B; Seth P; Mohapatra LN; Mitra AB; Bhatnagar P; Prabhakar AK; Agarwal SS
Indian J Med Res; 1983 Jul; 78 Suppl():60-6. PubMed ID: 6654432
[No Abstract] [Full Text] [Related]
14. Unusual serologic response to two patients to an early antigen of herpes simplex virus type 2.
Arsenakis M; May JT
Sex Transm Dis; 1982; 9(3):143-5. PubMed ID: 6293106
[TBL] [Abstract][Full Text] [Related]
15. A population-based seroepidemiological study of cervical cancer.
Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
[TBL] [Abstract][Full Text] [Related]
16. [Humoral immunity to herpes simplex virus type 2 in cervical cancer].
Posevaia TA; Barinskiĭ IF; Grigor'ev VV; Shuvaeva NI
Vopr Virusol; 1982; 27(3):328-30. PubMed ID: 6289530
[TBL] [Abstract][Full Text] [Related]
17. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
18. Humoral-and cell-mediated immune responses to herpesvirus antigens in patients with cervical carcinoma.
Kumar A; Selim MS; Madden DL; Wallen WC; Vasquez HH; Nankervis GA
Gynecol Oncol; 1980 Aug; 10(1):18-25. PubMed ID: 6249698
[No Abstract] [Full Text] [Related]
19. Prevalence of serum antibodies to herpes simplex virus types 1 and 2: application of an ELISA technique to 100 cases of anogenital herpes.
Devillechabrolle A; Hugues-Dorin F; Fortier B; Catalan F; Huraux JM
Sex Transm Dis; 1985; 12(1):40-3. PubMed ID: 2988144
[TBL] [Abstract][Full Text] [Related]
20. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
Xu ZH
Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
